Mynvax
Bangalore, India · $6.8M raised
- Headquarters
- Bangalore
- Employees
- 11–50
- Business Model
- B2B
- Website
- mynvax.com
- Total Funding
- $6.8M
- Last Round
- $2.6M Series AMay 2024
- Rounds
- 2
About
Clinical-stage biotech developing thermostable recombinant vaccines for respiratory viruses.
Summary
Mynvax is a Biotech company based in Bangalore, India. It has raised $6.8M in total across 2 rounds, most recently a $2.6M Series A round in May 2024. Investors include Inviga Healthcare Fund, Accel and LetsVenture.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company